Evidence map›Paper›PMID 40118846›Full record

ArticleNature communications2025

Comprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation.

Wener Li, Xiaojing Luo, Anna Strano, Shakthi Arun, Oliver Gamm, Mareike S Poetsch, Marcel Hasse, Robert-Patrick Steiner, Konstanze Fischer, Jessie Pöche and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. EV-Encapsulated Mitochondrial miRNAs: Enhancing Cardiomyocyte Bioenergetics.International journal of molecular sciences · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wener LiInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Xiaojing LuoInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Anna StranoInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Shakthi ArunInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Oliver GammInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Mareike S PoetschInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Marcel HasseInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Robert-Patrick SteinerInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Konstanze FischerInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Jessie PöcheInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Ying UlbrichtInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.
Mathias LescheDRESDEN-concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-3274-7163
Giulia TrimaglioInstitute of Clinical Chemistry and Laboratory Medicine, Department of Clinical Pathobiochemistry, University Hospital Dresden, Dresden, Germany.
Ali El-ArmoucheInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0003-2514-9429
Andreas DahlDRESDEN-concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-2668-8371
Peter MirtschinkInstitute of Clinical Chemistry and Laboratory Medicine, Department of Clinical Pathobiochemistry, University Hospital Dresden, Dresden, Germany.
Kaomei GuanInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany. kaomei.guan@tu-dresden.de.ORCID http://orcid.org/0000-0002-0753-3083
Mario SchubertInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Dresden, Germany. mario.schubert1@tu-dresden.de.ORCID http://orcid.org/0000-0002-8375-8233

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 288034826
6 · The paper itself

Abstract

The immaturity of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a major limitation for their use in drug screening to identify pro-arrhythmogenic or cardiotoxic molecules. Here, we demonstrate an approach that combines lipid-enriched maturation medium with a high concentration of calcium, nanopatterning of culture surfaces and electrostimulation to generate iPSC-CMs with advanced electrophysiological, structural and metabolic phenotypes. Systematic testing reveals that electrostimulation is the key driver of enhanced mitochondrial development and metabolic maturation and improved electrophysiological properties of iPSC-CMs. Increased calcium concentration strongly promotes electrophysiological maturation, while nanopatterning primarily facilitates sarcomere organisation with minor effect on electrophysiological properties. Transcriptome analysis reveals that activation of HMCES and TFAM targets contributes to mitochondrial development, whereas downregulation of MAPK/PI3K and SRF targets is associated with iPSC-CM polyploidy. These findings provide mechanistic insights into iPSC-CM maturation, paving the way for pharmacological responses that more closely resemble those of adult CMs.

Indexed as

Culture MediaInduced Pluripotent Stem CellsMyocytes, CardiacCalciumCell Culture TechniquesCell DifferentiationCells, CulturedElectric StimulationHumansMitochondriaCalciumCulture Media

Identifiers

PMID40118846
PMCPMC11928738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.